Rossi Joseph S, Flaherty James D, Fonarow Gregg C, Nunez Eduardo, Gattis Stough Wendy, Abraham William T, Albert Nancy M, Greenberg Barry H, O'Connor Christopher M, Yancy Clyde W, Young James B, Davidson Charles J, Gheorghiade Mihai
Northwestern University, Chicago, Illinois, United States.
Eur J Heart Fail. 2008 Dec;10(12):1215-23. doi: 10.1016/j.ejheart.2008.09.009. Epub 2008 Nov 8.
Coronary artery disease (CAD) is frequent among patients hospitalized with acute heart failure syndromes (AHFS).
To describe the influence of coronary revascularization status on survival in patients with AHFS.
OPTIMIZE-HF enrolled 48,612 patients with AHFS from 259 U.S. hospitals. In-hospital data were obtained for all patients and post-discharge 60-90 day follow-up in a pre-specified 10% sample. CAD was associated with higher in-hospital (3.7% vs. 2.9%, OR 1.14, 95% CI 1.00-1.31) and post-discharge mortality (9.2% vs. 6.9%, HR 1.37, 95% CI 1.03-1.81) compared to no CAD. Post-discharge, patients with CAD who were not revascularized had higher mortality compared to patients without CAD (10.6% vs. 6.9%, HR 1.56, 95% CI 1.15-2.11). This association was similar in patients with left ventricular systolic dysfunction (EF <40%, adjusted HR 1.52, 95% CI 0.98-2.35) and preserved systolic function (EF > or =40%, adjusted HR1.58, 95% CI 1.05-2.39). Patients with CAD who were revascularized had similar mortality to patients without CAD (HR 1.06, 95% CI 0.62-1.80 for PSF, HR 1.13, 95% CI 0.71-1.80 for LVSD).
In AHFS, patients with CAD have a higher 60-90 day post-discharge mortality compared to no-CAD patients. However, patients with CAD who are revascularized appear to have similar post-discharge mortality when compared to the no-CAD group. This suggests that revascularization status may confer a survival advantage in this high risk population.
冠状动脉疾病(CAD)在因急性心力衰竭综合征(AHFS)住院的患者中很常见。
描述冠状动脉血运重建状态对AHFS患者生存率的影响。
OPTIMIZE-HF研究纳入了来自美国259家医院的48,612例AHFS患者。获取了所有患者的住院数据,并对预先指定的10%样本进行出院后60 - 90天的随访。与无CAD患者相比,CAD患者的住院死亡率更高(3.7%对2.9%,比值比1.14,95%置信区间1.00 - 1.31),出院后死亡率也更高(9.2%对6.9%,风险比1.37,95%置信区间1.03 - 1.81)。出院后,未进行血运重建的CAD患者比无CAD患者的死亡率更高(10.6%对6.9%,风险比1.56,95%置信区间1.15 - 2.11)。这种关联在左心室收缩功能障碍(射血分数<40%,校正风险比1.52,95%置信区间0.98 - 2.35)和收缩功能保留(射血分数≥40%,校正风险比1.58,95%置信区间1.05 - 2.39)的患者中相似。进行了血运重建的CAD患者与无CAD患者的死亡率相似(射血分数保留患者的风险比1.06,95%置信区间0.62 - 1.80;左心室收缩功能障碍患者的风险比1.13,95%置信区间0.71 - 1.80)。
在AHFS中,与无CAD患者相比,CAD患者出院后60 - 90天的死亡率更高。然而,与无CAD组相比,进行了血运重建的CAD患者出院后死亡率似乎相似。这表明血运重建状态可能在这个高危人群中赋予生存优势。